The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis
Open accessAbstract
Genetic and pharmacological evidence suggests that overexpression of cyclooxygenase-2 (COX-2) is critical for epithelial carcinogenesis and provides a major target for cancer chemoprevention by nonsteroidal antiinflammatory drugs. Transgenic mouse lines with keratin 5 promoter-driven COX-2 overexpression in basal epidermal cells exhibit a preneoplastic skin phenotype. As shown here, this phenotype depends on the level of COX-2 expression and COX-2-mediated prostaglandin accumulation. The transgenics did not develop skin tumors spontaneously but did so after a single application of an initiating dose of the carcinogen 7,12-dimethylbenz[ a ]anthracene (DMBA). Long-term treatment with the tumor promoter phorbol 12-myristate 13-acetate, as required for tumorigenesis in wild-type mice, was not necessary for transgenics. The ratios of squamous cell carcinomas to papillomas and of sebaceous gland adenomas to papillomas plus squamous cell carcinomas were increased markedly in transgenic mice treated with DMBA alone compared with DMBA/phorbol 12-myristate 13-acetate-treated transgenic and wild-type mice. Thus, COX-2 overexpression, which leads to high levels of epidermal prostaglandin E 2 , prostaglandin F 2α , and 15-deoxy Δ12,14 -PGJ 2 , is insufficient for tumor induction but transforms epidermis into an “autopromoted” state, i.e., dramatically sensitizes the tissue for genotoxic carcinogens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cyclooxygenase regulates angiogenesis induced by colon cancer cells
Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., & DuBois, R. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81433-6 · Cited by 2,272
Cited by
The role of COX‐2 in intestinal inflammation and colorectal cancer
Wang, D., & DuBois, R. N. (2010) · Oncogene · doi:10.1038/onc.2009.421 · Cited by 805
Inflammation: Gearing the journey to cancer
KUNDU, J., & SURH, Y. (2008) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2008.03.002 · Cited by 803
Cancer chemopreventive and therapeutic potential of resveratrol: Mechanistic perspectives
Kundu, J. K., & Surh, Y.-J. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.057 · Cited by 473
COX-2: A Molecular Target for Colorectal Cancer Prevention
Brown, J. R., & DuBois, R. N. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.051 · Cited by 444
Cyclooxygenases in cancer: progress and perspective
Zha, S., Yegnasubramanian, V., Nelson, W. G., Isaacs, W. B., & De Marzo, A. M. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.06.014 · Cited by 389
RAGE signaling sustains inflammation and promotes tumor development
Gebhardt, C., Riehl, A., Durchdewald, M., Németh, J., Fürstenberger, G., Müller-Decker, K., Enk, A., Arnold, B., Bierhaus, A., Nawroth, P. P., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20070679 · Cited by 379
Chang, S.-H., Liu, C. H., Conway, R., Han, D. K., Nithipatikom, K., Trifan, O. C., Lane, T. F., & Hla, T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2535911100 · Cited by 361
COX-2 as a target for cancer chemotherapy
Ghosh, N., Chaki, R., Mandal, V., & Mandal, S. C. (2010) · Pharmacological Reports · doi:10.1016/s1734-1140(10)70262-0 · Cited by 344
Murakami, M., Nakashima, K., Kamei, D., Masuda, S., Ishikawa, Y., Ishii, T., Ohmiya, Y., Watanabe, K., & Kudo, I. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305108200 · Cited by 344
Garza, L. A., Liu, Y., Yang, Z., Alagesan, B., Lawson, J. A., Norberg, S. M., Loy, D. E., Zhao, T., Blatt, H. B., Stanton, D. C., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003122 · Cited by 308
Kim, S. O., Kundu, J. K., Shin, Y. K., Park, J.-H., Cho, M.-H., Kim, T.-Y., & Surh, Y.-J. (2005) · Oncogene · doi:10.1038/sj.onc.1208446 · Cited by 295
Kundu, J. K., Shin, Y. K., Kim, S. H., & Surh, Y.-J. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi349 · Cited by 271
Emerging avenues linking inflammation and cancer
Kundu, J. K., & Surh, Y.-J. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.02.035 · Cited by 264
Leng, J., Han, C., Demetris, J. A., Michalopoulos, G. K., & Wu, T. (2003) · Hepatology · doi:10.1053/jhep.2003.50380 · Cited by 258
Hung, J.-H., Su, I.-J., Lei, H.-Y., Wang, H.-C., Lin, W.-C., Chang, W.-T., Huang, W., Chang, W.-C., Chang, Y.-S., Chen, C.-C., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403568200 · Cited by 257
Actinic keratosis: a clinical and epidemiological revision
Schmitt, J. V., & Miot, H. A. (2012) · Anais Brasileiros de Dermatologia · doi:10.1590/s0365-05962012000300012 · Cited by 120
Müller-Decker, K. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9306-z · Cited by 73
“However, long-term treatment with the tumor promoter TPA, as required for tumorigenesis in wild-type mice, is not necessary for transgenic mouse lines [182], an effect that was also observed [198] with an independently generated single mouse line with a cytokeratin 14 promoter-driven COX-2 transgene [199].”
InfluentialSelf-citationInflammatory Events During Murine Squamous Cell Carcinoma Development
Gasparoto, T. H., de Oliveira, C. E., de Freitas, L. T., Pinheiro, C. R., Ramos, R. N., da Silva, A. L., Garlet, G. P., da Silva, J. S., & Campanelli, A. P. (2012) · Journal of Inflammation · doi:10.1186/1476-9255-9-46 · Cited by 35
Metadata
- Authors
- Müller-Decker, K., Neufang, G., Berger, I., Neumann, M., Marks, F., & Fürstenberger, G.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2002-09-09
- Volume
- 99
- Issue
- 19
- Pages
- 12483-12488
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2128100003
- Cited by
- 240
- References
- 1
- FWCI
- 13.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.